Daniel Margolis, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Promaxo
    Topic:
    ad-hoc consulting
    Date added:
    05/21/2023
    Date updated:
    05/20/2023
    Relationship end date:
    05/21/2023
Return to 2023 Annual Symposium For Evolving Therapies and Drug Development in Oncology: Targeted therapy, immunotherapy and beyond